Skip to main content
. 2024;25(9):3039–3049. doi: 10.31557/APJCP.2024.25.9.3039

Table 2.

Comparing Response between the 2 Groups

Palbociclib n=58 (%) Ribociclib n=58 (%) Significance P
Clinical benefit rate at 3 months 53 (91.4) 49 (84.5) 0.25
Clinical benefit rate at 6 months 34 (58.6) 34 (58.6)
Clinical benefit rate at 9 months 14 (24.1) 22 (37.9) 0.1
Clinical benefit rate at 12 months 8 (13.8) 10 (17.2) 0.79